243 related articles for article (PubMed ID: 24306957)
1. Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.
Lee H; Jun SY; Lee YS; Lee HJ; Lee WS; Park CS
Virchows Arch; 2014 Feb; 464(2):213-20. PubMed ID: 24306957
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
Xue M; Pang H; Li X; Li H; Pan J; Chen W
Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
[TBL] [Abstract][Full Text] [Related]
3. Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.
Dip N; Reis ST; Timoszczuk LS; Viana NI; Piantino CB; Morais DR; Moura CM; Abe DK; Silva IA; Srougi M; Dall'Oglio MF; Leite KR
J Urol; 2012 Nov; 188(5):1951-6. PubMed ID: 22999546
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.
Majid S; Dar AA; Saini S; Deng G; Chang I; Greene K; Tanaka Y; Dahiya R; Yamamura S
PLoS One; 2013; 8(7):e67686. PubMed ID: 23844063
[TBL] [Abstract][Full Text] [Related]
5. [Aberrant expressions of β-catenin and ZEB1 in bladder cancer and their significance].
Ning Z; Wu K; Fan J; Wang B; Lv C; Zhu J; Wang X; Hsieh JT; He D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1080-3. PubMed ID: 25270213
[TBL] [Abstract][Full Text] [Related]
6. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.
Bendoraite A; Knouf EC; Garg KS; Parkin RK; Kroh EM; O'Briant KC; Ventura AP; Godwin AK; Karlan BY; Drescher CW; Urban N; Knudsen BS; Tewari M
Gynecol Oncol; 2010 Jan; 116(1):117-25. PubMed ID: 19854497
[TBL] [Abstract][Full Text] [Related]
7. Novel ZEB1 expression in bladder tumorigenesis.
Kenney PA; Wszolek MF; Rieger-Christ KM; Neto BS; Gould JJ; Harty NJ; Mosquera JM; Zeheb R; Loda M; Darling DS; Libertino JA; Summerhayes IC
BJU Int; 2011 Feb; 107(4):656-63. PubMed ID: 20735391
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer.
Tsai YS; Jou YC; Tsai HT; Cheong IS; Tzai TS
Urol Oncol; 2019 Nov; 37(11):810.e17-810.e27. PubMed ID: 31253481
[TBL] [Abstract][Full Text] [Related]
9. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression.
Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W
Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084
[TBL] [Abstract][Full Text] [Related]
10. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
11. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
12. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.
Kim T; Veronese A; Pichiorri F; Lee TJ; Jeon YJ; Volinia S; Pineau P; Marchio A; Palatini J; Suh SS; Alder H; Liu CG; Dejean A; Croce CM
J Exp Med; 2011 May; 208(5):875-83. PubMed ID: 21518799
[TBL] [Abstract][Full Text] [Related]
13. miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.
Yue S; Wang L; Zhang H; Min Y; Lou Y; Sun H; Jiang Y; Zhang W; Liang A; Guo Y; Chen P; Lv G; Wang L; Zong Q; Li Y
Tumour Biol; 2015 Sep; 36(9):6741-9. PubMed ID: 25833697
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).
Jones TD; Cheng L
Histopathology; 2020 Oct; 77(4):525-535. PubMed ID: 32562556
[TBL] [Abstract][Full Text] [Related]
15. The study of miRNA-200c expression and epithelial-to-mesenchymal transition-related transcription factors in the primary bladder urothelial carcinoma.
Narwal A; Kumari K; Kaushal S; Seth A; Nayak B; Rustagi Y; Dinda AK
Urol Ann; 2023; 15(1):35-42. PubMed ID: 37006208
[TBL] [Abstract][Full Text] [Related]
16. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.
Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ
J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
Jones TD; Cheng L
Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
[TBL] [Abstract][Full Text] [Related]
18. Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
Wang CC; Huang CY; Jhuang YL; Chen CC; Jeng YM
Histopathology; 2018 Apr; 72(5):795-803. PubMed ID: 29193225
[TBL] [Abstract][Full Text] [Related]
19. Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder.
Roychowdhury A; Dey RK; Bandyapadhyay A; Bhattacharya P; Mitra RB; Dutta R
J Indian Med Assoc; 2012 Jun; 110(6):393-6. PubMed ID: 23360043
[TBL] [Abstract][Full Text] [Related]
20. Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
Zaleski M; Gogoj A; Walter V; Raman JD; Kaag M; Merrill SB; Drabick J; Joshi M; Holder S; DeGraff DJ; Warrick JI
Hum Pathol; 2019 Feb; 84():275-282. PubMed ID: 30359638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
